(J & J. Official Website, 2005) This is a wise description in that, rather than specializing in one arena of health care, Johnson and Johnsons diversity of products and character buffets it against some of the specific regulatory turmoil that has affected largely pharmaceutically-based health care companies, such as Pfizer and Merck. The stress on local managerial control also allows the companys diversity to be regionally specific and focused, tailored to the needs of its environment.
Its lack of directive control is a calculated strategic decision of control that allows regional branches of J&J both to take advantage of J&Js diversity as a company and to tailor the companys resources to the region commercially.
Strategic Control.” (2004) Johnson & Johnson Official Investor Website. Retrieved 1 Jan 2005 at http://www.investor.jnj.com/strategic.cfm.